z-logo
open-access-imgOpen Access
Predictors of Mortality among Tuberculosis/HIV-Coinfected Persons in Southwest Ethiopia
Author(s) -
Kebede Deribe,
Alemeshet Yami,
Amare Deribew,
Nebiyu Mesfin,
Robert Colebunders,
JeanPierre Van Geertruyden,
Mirkuzie Woldie,
T.M.M. Maja
Publication year - 2013
Publication title -
journal of the international association of providers of aids care (jiapac)
Language(s) - English
Resource type - Journals
eISSN - 2325-9582
pISSN - 2325-9574
DOI - 10.1177/2325957413500528
Subject(s) - medicine , tuberculosis , human immunodeficiency virus (hiv) , cohort , confidence interval , odds ratio , cohort study , antiretroviral therapy , mortality rate , coinfection , immunology , viral load , pathology
Background: Tuberculosis (TB) remains the most common cause of death in people living with HIV/AIDS. The aim of the present study was to identify predictors of mortality in TB/HIV-coinfected patients.Methods: We conducted an unmatched case–control study among a cohort of TB/HIV-coinfected adults who were on antiretroviral therapy (ART). Cases comprised 69 TB/HIV-coinfected patients who died during this period. For each case, we selected 3 (207) TB/HIV-coinfected patients who were alive during the end of the follow-up period.Results: Male sex (odds ratio [OR] = 2.04, 95% confidence interval [CI]: 1.04-4.02), being bedridden at enrollment (OR = 2.84, 95% CI: 1.17-6.89), and cough of more than 2 weeks during initiation of ART (OR = 4.75 95% CI: 2.14-10.56) were the best predictors of mortality among TB/HIV-coinfected patients.Conclusion: Mortality among TB/HIV-coinfected patients accounted for a considerable number of deaths among the cohort. Patients with cough at ART initiation and with poor functional status should be strictly followed to reduce death.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom